News

REACT: HIV reactivation and targeted removal by gene editing

QVQ has intensified its collaboration with the research group of @Monique Nijhuis (Translational Virology, UMCU). The REACT project, part of Health Holland TKI-LSH, will investigate possible utilization of our anti-HIV single domain antibody products with mRNA containing lipid nanoparticles (LNPs).

We are happy to collaborate with Monique, Single Cell Discoveries and the HIV foundation in this interesting project. QVQ anticipates that the approaches aimed to be developed in this project will have the potential to be widely applicable.